We are MMCORC, a #NCORP of 22 community hospitals and oncology clinics with over 250 providers offering #ClinicalTrials to people in their own communities.
- Tweets 514
- Following 74
- Followers 77
- Likes 280
ALT mmcorc.org
ALT This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab and chemotherapy may help stabilize lung cancer.
ALT https://clinicaltrials.gov/study/NCT07383441?term=BIOFRONT&viewType=Card&spons=COVERAGE%5BFullMatch%5DSWOG%20Cancer%20Research%20Network&rank=1
ALT Free online trainings are available for CHWs to advance knowledge on health promotion and chronic disease prevention topics. These online courses are intended to build upon the core competencies of the CHW Certificate Program in Minnesota.
ALT The Alliance for Clinical Trials in Oncology seeks to reduce the impact of cancer by uniting a broad community of scientists and clinicians who are committed to the prevention and treatment of cancer.
ALT The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) is a membership-based scientific organization that designs and conducts cancer research involving adults who have or are at risk of developing cancer. We are a strong network of nearly 1400 academic and community-based cancer centers and hospitals in the United States and around the world. MMCORC provides local enrollment to these groundbreaking clinical trials, close to home.
